Health

Results: 1549-1560 of 10154

VahatiCor CEO, Harry D. Rowland, Ph.D.

VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer

PR Newswire associated0

LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

Business Wire logo

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Selects MEVION S250-FIT™ for Southern Italy’s First Proton Therapy Center

United Imaging Unveils Its Full Radiotherapy Portfolio at ESTRO 2026, Highlighting the CE-Marked uRT-linac 506c

PR Newswire associated0

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

PR Newswire associated0

Recor Medical Highlights Innovation and Global Action on World Hypertension Day 2026

Business Wire logo

Organon to Present New Research on Access and Value at ISPOR 2026

Eisai projects Leqembi® revenue to total JPY 143.5 billion for fiscal year 2026 (April 2026 - March 2027)

PR Newswire associated0

Ozelle Wins German Innovation Award Gold for Advancing the Fourth Generation of Hematology Analysis

Business Wire logo

Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet

PR Newswire associated0

/C O R R E C T I O N -- Advita Ortho, LLC/

ESGE Days 2026: Endoscopic procedure associated with greater short-term weight loss than oral semaglutide, study finds